4.7 Editorial Material

PCSK9 Inhibition for Therapeutic Decision-Making Assessing the Value

Journal

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Volume 75, Issue 18, Pages 2309-2311

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jacc.2020.03.037

Keywords

acute coronary syndromes; alirocumab; cholesterol; cost-effectiveness; economic analysis

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available